Satoshi Okada
Impact in
- Immunology top 0.1%
- Immunodeficiency and Autoimmune Disorders
- Immune Cell Function and Interaction
- interferon and immune responses
- T-cell and B-cell Immunology
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Immunology 132
- Immunodeficiency and Autoimmune Disorders 97
- Immune Cell Function and Interaction 29
- T-cell and B-cell Immunology 16
- interferon and immune responses 14
- Immune Response and Inflammation 12
- Genetics 63
- Blood disorders and treatments 37
- Co-authors
- Masao Kobayashi (50 shared papers)Jean-Laurent Casanova (18 shared papers)Anne Puel (12 shared papers)Stéphanie Boisson‐Dupuis (6 shared papers)Miyuki Tsumura (43 shared papers)Alan M. Krensky (6 shared papers)Carol Clayberger (5 shared papers)Xiao‐Fei Kong (3 shared papers)
- Journals
- Journal of Clinical Immunology (25 papers)The Journal of Experimental Medicine (18 papers)Journal of Allergy and Clinical Immunology (16 papers)Frontiers in Immunology (10 papers)Science (6 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Satoshi Okada
287 papers receiving 16.0k citations
Satoshi Okada's Hit Papers
Peers
Comparison fields: 5 of 161
- Immunology 8.1k
- Infectious Diseases 4.7k
- Neurology 1.4k
- Genetics 2.4k
- Epidemiology 2.6k
Countries citing papers authored by Satoshi Okada
This map shows the geographic impact of Satoshi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Okada more than expected).
Fields of papers citing papers by Satoshi Okada
This network shows the impact of papers produced by Satoshi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Okada. The network helps show where Satoshi Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Satoshi Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2063 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1718 |
| 3 | Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis Hit paper breakdown → | 2011 | 674 |
| 4 | Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Hit paper breakdown → | 2021 | 466 |
| 5 | 2012 | 456 | |
| 6 | Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation Hit paper breakdown → | 2014 | 456 |
| 7 | Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype Hit paper breakdown → | 2016 | 450 |
| 8 | 2015 | 379 | |
| 9 | 2018 | 362 | |
| 10 | 2015 | 355 | |
| 11 | 2015 | 295 | |
| 12 | Human genetic and immunological determinants of critical COVID-19 pneumonia Hit paper breakdown → | 2022 | 275 |
| 13 | 2012 | 226 | |
| 14 | 2015 | 180 | |
| 15 | 2020 | 171 | |
| 16 | 2011 | 169 | |
| 17 | 2015 | 164 | |
| 18 | 2018 | 162 | |
| 19 | 2018 | 158 | |
| 20 | 2003 | 151 |
About Satoshi Okada
Satoshi Okada is a scholar working on Immunology, Genetics, Infectious Diseases, Epidemiology and Genetics, having authored 321 papers that have together received 16.3k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (97 papers), Blood disorders and treatments (37 papers), Immune Cell Function and Interaction (29 papers), T-cell and B-cell Immunology (16 papers), interferon and immune responses (14 papers), Metabolism and Genetic Disorders (13 papers), Mycobacterium research and diagnosis (13 papers) and Immune Response and Inflammation (12 papers). The work is most often cited by research in Immunology (8.1k citations), Infectious Diseases (4.7k citations), Neurology (1.4k citations), Genetics (2.4k citations) and Epidemiology (2.6k citations). Satoshi Okada has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Masao Kobayashi, Jean-Laurent Casanova, Anne Puel, Stéphanie Boisson‐Dupuis, Miyuki Tsumura, Alan M. Krensky, Carol Clayberger, Xiao‐Fei Kong, Yoko Mizoguchi and Sophie Cypowyj. Their work appears in journals such as Journal of Clinical Immunology, The Journal of Experimental Medicine, Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.